NEU neuren pharmaceuticals limited

Ann: Fundamentals strong as Neuren advances neuroscience pipeline, page-11

  1. 1,253 Posts.
    lightbulb Created with Sketch. 310
    Fair point Rovers everything is for sale at the right price - I don't think there is an appetite to pay the big bucks up front for what NEU has in the bank at this point in time, and the Acadia deal or lack thereof I think backs that sentiment up. I can't see a big deal getting across the line until P3 results are in, and if it is a positive outcome NEU gets to name their price and that is what I am here for.

    Not saying things won't change but I can't see it at the moment. It makes sense to appoint Torreya as they should be talking to big pharma, P3 is going ahead this year so they need to get set. BTW you only have to note the current SP action to see there is not much interest. GLA MOO DYOR
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.10
Change
-0.800(5.76%)
Mkt cap ! $1.629B
Open High Low Value Volume
$13.95 $13.96 $12.88 $9.534M 725.6K

Buyers (Bids)

No. Vol. Price($)
1 266 $13.10
 

Sellers (Offers)

Price($) Vol. No.
$13.15 1619 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.